Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Lars Køber, Rana Rustom, Jonas Wiedmann, Anne-Marie Kappelgaard, Meguid El Nahas, Bo Feldt-Rasmussen

The high morbidity and mortality rates in hemodialysis (HD) patients are due, at least in part, to their increased risk for cardiovascular diseases (CVD). This prospective study evaluated the effect of growth hormone (GH) on a number of CVD risk markers in adult patients on HD.
OriginalsprogEngelsk
TidsskriftNephron Clinical Practice
Vol/bind115
Udgave nummer3
Sider (fra-til)c213-26
Antal sider14
ISSN1660-2110
DOI
StatusUdgivet - 1 jan. 2010

ID: 34154046